TY  - GEN
AU  - Cobble,Michael E
AU  - Frederich,Robert
TI  - Saxagliptin for the treatment of type 2 diabetes mellitus: assessing cardiovascular data
SN  - 1475-2840
PY  - 2012///0606
KW  - Adamantane
KW  - adverse effects
KW  - Cardiovascular Diseases
KW  - etiology
KW  - Clinical Trials as Topic
KW  - Diabetes Complications
KW  - Diabetes Mellitus, Type 2
KW  - complications
KW  - Dipeptides
KW  - Dipeptidyl-Peptidase IV Inhibitors
KW  - Drug Therapy, Combination
KW  - Evidence-Based Medicine
KW  - Humans
KW  - Patient Safety
KW  - Proportional Hazards Models
KW  - Risk Assessment
KW  - Risk Factors
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review
UR  - https://doi.org/10.1186/1475-2840-11-6
ER  -